Serum levels of coenzyme Q 10 in patients with amyotrophic lateral sclerosis

Journal of Neural Transmission

Volumn 107, Issue 8-9, 2000, Pages 1021-1026

  Molina, J A ^a   De Bustos, F ^b   Jimenez Jimenez F J ^c   Gomez Escalonilla C ^a   Garcia Redondo A ^b   Esteban, J ^a   Guerrero Sola, A ^d   Del Hoyo, P ^b   Martinez Salio A ^a   Ramirez Ramos C ^d   Ruiz Indurain, G ^a   Arenas, J ^b  

^a Department of Neurology ^*

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Amyotrophic lateral sclerosis; Coenzyme Q 10; Motoneuron disease; Serum levels

Indexed keywords

UBIDECARENONE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; MOTOR NEURON DISEASE; PRIORITY JOURNAL; RISK FACTOR;

AGE FACTORS; AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; UBIQUINONE;

EID: 0033784463     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020070050     Document Type: Article

References (21)

1. Oxidative stress: Its role in the pathogenesis of amyotrophic lateral sclerosis
2. Copper/zinc superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis motorneurons
3. Mecanismos de degeneracion neuronal en la esclerosis lateral amiotrofica
4. Amyotrophic lateral sclerosis: Oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes
5. Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis
6. Biochemical, physiological and medical aspects of ubiquinone function
7. Benefit of vitamin E, riluzole, and gabapentine in a transgenic model of familial amyotrophic lateral sclerosis
8. Vitamin A and E levels are normal in amyotrophic lateral sclerosis
9. Estres oxidativo y sistema nervioso central
10. 10 in human plasma as a possible marker of oxidative stress
11. Increased [35S]glutathione binding sites in spinal cords from patients with sporadic amyotrophic lateral sclerosis
12. Therapeutic advances in amyotrophic lateral sclerosis
13. Serum levels of beta-carotene, alpha-carotene, and vitamin A in patients with amyotrophic lateral sclerosis
14. Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients
15. Mutations in Cu/Zn superoxide distmutase gene are associated with familial amyotrophic lateral sclerosis
16. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons
17. Antioxidant drugs block in vitro the neurotoxicity of CSF from patients with amyotrophic lateral sclerosis
18. α-Tocopherol quinone level is remarkably low in the cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis
19. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis
20. EI Escorial WFN criteria for the diagnosis of amyotrophic lateral sclerosis